NCT02425410

Brief Summary

The purpose of this study is to investigate viral factors determining the early onset of T1D. Thanks to the quantification of viral exposures of T1D patients before the disease onset with questionnaires and environmental databases analyses, and through whole genome association studies of these patients, investigators could attempt to identify gene-virus interactions determining the age of T1D onset.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2010

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2010

Completed
4.4 years until next milestone

First Submitted

Initial submission to the registry

August 7, 2014

Completed
9 months until next milestone

First Posted

Study publicly available on registry

April 24, 2015

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2018

Completed
Last Updated

June 28, 2016

Status Verified

June 1, 2016

Enrollment Period

7.8 years

First QC Date

August 7, 2014

Last Update Submit

June 27, 2016

Conditions

Keywords

Diabetes MellitusInsulin-DependentVirus DiseasesQuestionnairesRisk assessmentGenome-Wide Association Study

Outcome Measures

Primary Outcomes (2)

  • Occurrence of viral events before T1D diagnosis

    From birth to 2 years

  • Delay between viral events and T1D diagnosis

    From birth to 2 years

Secondary Outcomes (1)

  • Age at T1D diagnosis as a quantitative trait

    From birth to 2 years

Study Arms (1)

Isis-Virus

T1D patients of the Isis-Diab cohort with genetic data (GWAS) and specific environmental data on viral events during childhood

Other: Collect of data on viral environment of T1D patientsGenetic: Collect of blood samples for DNA extraction and genetic characterization (GWAS)

Interventions

Questionnaires on viral events during mother's pregnancy and patient's childhood, health book copies, addresses' geolocation, quantification of viral exposures using Sentinel Network data

Isis-Virus

Collect of blood samples for DNA extraction and genetic characterization (GWAS) on Illumina platform (Centre National de Genotypage)

Isis-Virus

Eligibility Criteria

Age6 Months+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients of the Isis-Diab cohort, i.e. T1D patients aged more than 6 months, already sampled for genetic analysis.

You may qualify if:

  • Type 1 diabetic patients included in the Isis-Diab cohort
  • Patients with available genetic data (GWAS)

You may not qualify if:

  • Patient refusal (or parents) to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Inserm U986

Le Kremlin-Bicêtre, 94276, France

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

whole blood (already collected for the Isis-Diab project)

MeSH Terms

Conditions

Diabetes MellitusVirus Diseases

Interventions

Genome-Wide Association Study

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesInfections

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesMolecular EpidemiologyGenetic Association StudiesGenetic TechniquesOligonucleotide Array Sequence AnalysisSequence AnalysisPublic HealthEnvironment and Public Health

Study Officials

  • Alain-Jacques Valleron, PhD

    Institut National de la Santé Et de la Recherche Médicale, France

    PRINCIPAL INVESTIGATOR
  • Pierre Bougnères, MD, PhD

    Inserm U986 / Pediatric endocrinology department of the Bicêtre Hospital (AP-HP)

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 7, 2014

First Posted

April 24, 2015

Study Start

March 1, 2010

Primary Completion

December 1, 2017

Study Completion

June 1, 2018

Last Updated

June 28, 2016

Record last verified: 2016-06

Locations